Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 1 results out of 1                                
                                
                                                Data Insights
                                                
                                        MR-139 by Viatris for Blepharitis: Likelihood of Approval
MR-139 is under clinical development by Viatris and currently in Phase III for Blepharitis. According to GlobalData, Phase III drugs...